• / Free eNewsletters & Magazine
  • / My Account
Home>Medtronic in FDA Consent Decree Over SynchroMed Infusion Pump -- Update

Medtronic in FDA Consent Decree Over SynchroMed Infusion Pump -- Update

3party Content

Tue, 28 Apr 2015

By Thomas M. Burton Federal authorities reached a proposed consent agreement with medical device maker Medtronic Inc. over flaws in its SynchroMed drug-infusion pump for cancer and pain medicine, a device that has been linked to serious injuries and deaths in recent years. The Justice Department,
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.